欧洲心脏病学会(ESC)2015年度会议于8月29日9月2日在英国伦敦召开。来自全球140个国家的3万余名医疗及相关人员参会,共同分享了心血管领域的新理念与新进展。本次会议上公布了4项高血压临床试验,涉及对传统及新兴的抗高血压药物的评价,使得血压成为本次ESC会议的热点领域之一。本文简要介绍这4项临床试验并对其临床意义进行解析,以期对临床高血压的治疗及血压管理有所 The 2015 annual meeting of the European Society of Cardiology (ESC) was held on August 29 and September 2 in London, England. More than 30,000 medical and related personnel from 140 countries around the world attended the conference to share new ideas and progress in cardiovascular field. Four high blood pressure clinical trials were announced at this meeting, which involved the evaluation of traditional and emerging antihypertensives and made blood pressure one of the hot topics in this ESC meeting. This article briefly describes the four clinical trials and analysis of its clinical significance, with a view to the treatment of clinical hypertension and blood pressure management